Leafy Tunnel
Overview
Leafy Tunnel is an early-stage venture firm investing in alternative medicine to address major healthcare challenges including mental health and pain disorders.
Investment Focus
- Companies focused on alternative medicine
- Addressing mental health and pain disorders
- Primarily in the European market
- Seed and Series A stages
- Commitment to ethical and sustainable practices
- Innovative approaches to healthcare
- Potential for positive impact on patients and families
- Alignment with Leafy Tunnel's mission and vision
Portfolio Companies
Reach Leafy Tunnel directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Leafy Tunnel
What sectors does Leafy Tunnel invest in?
Leafy Tunnel invests in Healthcare, Pharmaceuticals, Medical Devices, Biotech, Clinical Trials and Supply Chain Management, and is based in Westminster, United Kingdom. Leafy Tunnel is listed as a venture capital in the ConnectSafely investor database.
What stage does Leafy Tunnel invest at?
Leafy Tunnel backs companies at Seed and Series A, writing cheques of 1M - 5M.
Which regions does Leafy Tunnel invest in?
Leafy Tunnel invests across United States, United Kingdom, Canada, Japan, Australia and Europe.
Who are the partners at Leafy Tunnel?
Team members listed for Leafy Tunnel include Nikolay Tretiyakov (Founding Partner) and Dennis Tran (Principal).
What companies has Leafy Tunnel invested in?
Leafy Tunnel's portfolio includes Lyphe Group.
How do I contact Leafy Tunnel?
Leafy Tunnel's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
